Market Access/ News/ News/ News/ R&D Opdivo and Keytruda approved in new lung cancer uses Piotr Wnuk Bristol-Myers Squibb, FDA approval, Opdivo, SCLC, small cell lung cancer 0 Comment The FDA has approved Merck’s Keytruda (pembrolizumab) as a combination treatment for metastatic nonsquamous non-small cell lung cancer Share X Opdivo and Keytruda approved in new lung cancer uses https://pharmaphorum.com/news/bmss-opdivo-approved-lung-cancer/
Bristol-Myers Squibb, FDA approval, Opdivo, SCLC, small cell lung cancer
0 Comment
